CommunityRx EMR program connects patients with neighborhood resources

Connecting patients with healthcare resources within their own community can increase medication adherence and improve quality of life. Researchers at the University of Chicago Medicine have developed a program that uses electronic medical records (EMRs) to connect patients with the health resources in their community.

The CommunityRx program is able to provide patients with personalized e-prescriptions, called HealtheRx, in three dozen health clinics with both adult and pediatric care. Since 2012, the program has been able to produce over 506,000 HealtheRx prescriptions for 200,000 patients. By connecting patients with care facilities that meet specific needs, the programs improves care options while also keeping patients close to their treatment centers.

Patient information is stored and updated on a database of community assets with EMRs. The database includes 20,000 community facilities ranging from food banks to counseling centers and covers 107 square miles of Chicago's South Side.

In a study analyzing the effectiveness of the program, researchers surveyed 458 participants in the CommunityRx program. Results showed that, between 2012 and 2014, 83 percent of participants rated the personalized referrals as “very useful.” One in five participants visited a place recommend by the program. Over the three year period of the study, the program provided 250,000 prescriptions for 113,000 patients. In all health facilities, all but six continued to use CommunityRx after the conclusion of the study.

"To me, the most profound finding and one that motivated me to find a sustainable business model, was that more than half the participants surveyed used their HealtheRx to help connect someone else to community resources," said Stacy Tessler Lindau, MD, an associate professor of obstetrics and gynecology at the University of Chicago. "I'm fascinated by the idea that we might motivate people to take better care of themselves by offering them a tool that make it easy to help others."

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.